AKTX Akari Therapeutics
8,912
$1.45
$0.11
(8.21%)
| Watchers | 8,912 |
| 52-Wk Low | $1.08 |
| 52-Wk High | $5.50 |
| Market Cap | $8.87M |
| Volume | 12,419.00 |
| 52-Wk High | $5.50 |
| 52-Wk Low | $1.08 |
Akari Therapeutics Non-GAAP EPS of $0.00SeekingAlpha.com: All News • about 1 month ago
Akari Therapeutics Non-GAAP EPS of $0.00...
Share to Feed
BOSTON and LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory...
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX PR Newswire NEW YORK, March 18, 2024 NEW YORK, March...
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of Monteverde & Associates PC (the M&A Class Action Firm ), has recovered money for shareholders and is...
Equities research analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX Get Free Report) in a research report issued to clients and investors on Friday. The...
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm PR Newswire NEW YORK, March 15, 2024 NEW...
Equities researchers at StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX Get Free Report) in a research note issued to investors on Thursday. The brokerage set a...
NEW YORK, March 09, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...